DR. LEVY is clinical professor of medicine at the University of Arizona, Phoenix, and an advisory member of the AACE board of directors. He has received speaker honoraria from Amylin Pharmaceuticals Inc., GlaxoSmithKline Inc., Daiichi Sankyo, Eli Lilly & Co., Novo Nordisk, and other companies that make diabetes therapies.
PREVIEW
DR. LEVY is clinical professor of medicine at the University of Arizona, Phoenix, and an advisory member of the AACE board of directors. He has received speaker honoraria from Amylin Pharmaceuticals Inc., GlaxoSmithKline Inc., Daiichi Sankyo, Eli Lilly & Co., Novo Nordisk, and other companies that make diabetes therapies.